Share

Protean eGov Technologies Limited Stocks

590.2Last Updated 27.02.2026

Issuer Rating

4/7

Performance

Favourable

Risk

Moderate

Recommendation

Hold

Market Cap

₹ 263.45M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
590.2
Key Takeaways

Risk factor

Meaningful price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Protean eGov Technologies Ltd. is an information technology enabled solution company that engages in conceptualizing, developing and executing nationally critical and population scale greenfield technology solutions. It collaborates with the government in creating digital public infrastructure and developing citizen-centric e-governance solutions. The firm provides corporate and retail services. The corporate services include e-Governance solutions, system...

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of PROTEAN.BO is 1290 and suggests 119% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks